Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (51-60 of 760) with videos related to

Pageof 76
Sort By:
Interventional Cardiology Clinics|November 26, 2016
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs?Davide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|September 21, 2019
Reply: Platelet Function and Genetic Testing in Patients Receiving Oral Anticoagulation and Antiplatelet Treatment: An Area of Unmet NeedDirk Sibbing, Dominick J Angiolillo
Circulation. Cardiovascular Interventions|February 20, 2014
Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventionsDavide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|January 10, 2019
Tailoring Antiplatelet Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: Navigating the UnknownDavide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|June 6, 2024
Ticagrelor in Clopidogrel-Treated Patients With Chronic Coronary Syndrome Undergoing PCI: Translating Pharmacodynamic Into Clinical EvidenceClaudio Laudani, Dominick J Angiolillo
Journal of the American College of Cardiology|March 19, 2013
Targeting p-selectin during coronary interventions: the elusive link between inflammation and platelets to prevent myocardial damageFernando Alfonso, Dominick J Angiolillo
Circulation|May 31, 2012
Antithrombotic therapy in patients with chronic kidney diseaseDavide Capodanno, Dominick J Angiolillo
Journal of the American Heart Association|December 11, 2020
When Less Becomes More: Insights on the Pharmacodynamic Effects of Aspirin Withdrawal in Patients With Potent Platelet P2Y<sub>12</sub> Inhibition Induced by TicagrelorDavide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|April 7, 2021
Antithrombotic Management of Elderly Patients With Coronary Artery DiseasePiera Capranzano, Dominick J Angiolillo
JACC. Cardiovascular Interventions|April 7, 2021
Evidence and Recommendations for Uninterrupted Versus Interrupted Oral Anticoagulation in Patients Undergoing Percutaneous Coronary InterventionPiera Capranzano, Dominick J Angiolillo
Pageof 76

Showing results (51-60 of 760) with videos related to

Sort By:
Pageof 76
Interventional Cardiology Clinics|November 26, 2016
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs?Davide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|September 21, 2019
Reply: Platelet Function and Genetic Testing in Patients Receiving Oral Anticoagulation and Antiplatelet Treatment: An Area of Unmet NeedDirk Sibbing, Dominick J Angiolillo
Circulation. Cardiovascular Interventions|February 20, 2014
Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventionsDavide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|January 10, 2019
Tailoring Antiplatelet Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: Navigating the UnknownDavide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|June 6, 2024
Ticagrelor in Clopidogrel-Treated Patients With Chronic Coronary Syndrome Undergoing PCI: Translating Pharmacodynamic Into Clinical EvidenceClaudio Laudani, Dominick J Angiolillo
Journal of the American College of Cardiology|March 19, 2013
Targeting p-selectin during coronary interventions: the elusive link between inflammation and platelets to prevent myocardial damageFernando Alfonso, Dominick J Angiolillo
Circulation|May 31, 2012
Antithrombotic therapy in patients with chronic kidney diseaseDavide Capodanno, Dominick J Angiolillo
Journal of the American Heart Association|December 11, 2020
When Less Becomes More: Insights on the Pharmacodynamic Effects of Aspirin Withdrawal in Patients With Potent Platelet P2Y<sub>12</sub> Inhibition Induced by TicagrelorDavide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|April 7, 2021
Antithrombotic Management of Elderly Patients With Coronary Artery DiseasePiera Capranzano, Dominick J Angiolillo
JACC. Cardiovascular Interventions|April 7, 2021
Evidence and Recommendations for Uninterrupted Versus Interrupted Oral Anticoagulation in Patients Undergoing Percutaneous Coronary InterventionPiera Capranzano, Dominick J Angiolillo
Pageof 76